Testing a new mitral valve repair device
Part of Heart & circulation clinical trials.
This trial tests a new device called AMEND™ that is placed through a vein in the leg to repair a leaky mitral valve without open-heart surgery. It is for people with significant mitral regurgitation who are at high risk for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 21.
- You have moderate-to-severe or severe mitral regurgitation (leaky valve) that causes symptoms like shortness of breath.
- Your heart's pumping strength is more than 30%, and the main pumping chamber is not too enlarged.
- You are considered high-risk for open-heart surgery by your heart team.
- You have been stable on heart failure medications for at least one month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
This trial is testing a new device to help people with severe mitral regurgitation (a leaky heart valve) who cannot have open-heart surgery or a valve clip. The device is placed using a thin tube through a blood vessel, and aims to improve symptoms and quality of life.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This trial tests a new device called the SATURN system, which places a new mitral valve without open-heart surgery. It is for people aged 65 and older with severe mitral regurgitation who are at high risk for surgery.
Hear when a new Symptomatic Functional MR 3 or Greater trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.